Achieve Life Sciences ACHV
NASDAQ ACHV
$7.24 -0.29 (-3.85%)
At close: Oct 2, 2026 · 4:00 PM EDT

Achieve Life Sciences (ACHV) Cash & Equivalents (2010 - 2026)

Updated

Achieve Life Sciences (ACHV) recorded Cash & Equivalents of $47.96 million in Q2 2026, down 7.5% from $51.87 million a year earlier but up 70.8% from the prior quarter.

Analysis

Achieve Life Sciences (ACHV) Cash & Equivalents (2010 - 2026) Analysis & Trends

At the end of FY2025, Achieve Life Sciences reported Cash & Equivalents of $20.93 million, up 64.1% from FY2024.

  • Annual Cash & Equivalents has a five-year compound annual growth rate of -10.2% (FY2020 to FY2025).
  • Across earlier years, Cash & Equivalents came in at $12.75 million in FY2024 (-18.0%), $15.55 million in FY2023 (-37.2%), $24.77 million in FY2022 (-42.4%) and $43.02 million in FY2021 (+20.0%).
  • Quarterly Cash & Equivalents has ranged from $9.54 million in Q3 2024 to $66.4 million in Q1 2024 over the past five years.
  • On a year-over-year basis, Cash & Equivalents rose in four of the last eight quarters, with growth averaging 63.5%.
  • Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 302.1% in Q1 2024, against a decline of 80.4% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $28.08 million (Q1 2026), $20.93 million (Q4 2025) and $31.93 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 20.42 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 6.57 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 4.89 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 3.18 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 976.00 Mn
10 Achieve Life Sciences 328.27 Mn 328.27 Mn - 47.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 47.96 Mn
Mar 31, 2026 28.08 Mn
Dec 31, 2025 20.93 Mn
Sep 30, 2025 31.93 Mn
Jun 30, 2025 51.87 Mn
Mar 31, 2025 13.02 Mn
Dec 31, 2024 12.75 Mn
Sep 30, 2024 9.54 Mn
Jun 30, 2024 14.76 Mn
Mar 31, 2024 66.40 Mn
Dec 31, 2023 15.55 Mn
Sep 30, 2023 19.92 Mn
Jun 30, 2023 25.10 Mn
Mar 31, 2023 16.51 Mn
Dec 31, 2022 24.77 Mn
Sep 30, 2022 18.20 Mn
Jun 30, 2022 29.40 Mn
Mar 31, 2022 36.34 Mn
Dec 31, 2021 43.02 Mn
Sep 30, 2021 33.31 Mn
API Access

Achieve Life Sciences Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ACHV&period=max&api_key=YOUR_API_KEY